Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities
出版年份 2013 全文链接
标题
Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities
作者
关键词
-
出版物
NATURE MEDICINE
Volume 19, Issue 11, Pages 1518-1523
出版商
Springer Nature
发表日期
2013-09-30
DOI
10.1038/nm.3328
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells
- (2013) Ha-Na Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Essential Role of Gli Proteins in Glioblastoma Multiforme
- (2013) Matteo Santoni et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
- (2012) Yan Wang et al. CANCER CELL
- Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures
- (2012) Sandrine Eimer et al. NEURO-ONCOLOGY
- Antitumor Activity of NVP-BKM120--A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
- (2011) D. Koul et al. CLINICAL CANCER RESEARCH
- Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy
- (2011) Monica Venere et al. GLIA
- In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines
- (2011) Pietro Ferruzzi et al. INTERNATIONAL JOURNAL OF CANCER
- Differential Retinoic Acid Signaling in Tumors of Long- and Short-term Glioblastoma Survivors
- (2011) Sebastian Barbus et al. JNCI-Journal of the National Cancer Institute
- Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor
- (2011) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency
- (2011) P. Tandon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
- (2010) P. Workman et al. CANCER RESEARCH
- New developments in the discovery of small molecule Hedgehog pathway antagonists
- (2010) Martin R Tremblay et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells
- (2010) Antony Hsieh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Novel Medical Therapeutics in Glioblastomas, Including Targeted Molecular Therapies, Current and Future Clinical Trials
- (2010) Eudocia C. Quant et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Automated Network Analysis Identifies Core Pathways in Glioblastoma
- (2010) Ethan Cerami et al. PLoS One
- Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma
- (2010) Robert C. Castellino et al. PLoS One
- Hedgehog pathway-regulated gene networks in cerebellum development and tumorigenesis
- (2010) E. Y. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
- (2010) S. Buonamici et al. Science Translational Medicine
- Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
- (2010) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
- (2009) Steven M. Pollard et al. Cell Stem Cell
- Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
- (2009) Shinji Mizuarai et al. Molecular Cancer
- Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor-Induced Gliomas
- (2008) O. J. Becher et al. CANCER RESEARCH
- Death through a tragedy: mitotic catastrophe
- (2008) H Vakifahmetoglu et al. CELL DEATH AND DIFFERENTIATION
- The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†
- (2008) Adrian J. Folkes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Kinome siRNA Screen Identifies Regulators of Ciliogenesis and Hedgehog Signal Transduction
- (2008) M. Evangelista et al. Science Signaling
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started